<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2019-1-101-112</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-996</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Регенеративная медицина и клеточные технологии</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Regenerative Medicine and Cell Technologies</subject></subj-group></article-categories><title-group><article-title>Сравнительное исследование процесса хондрогенной дифференцировки мезенхимальных стромальных клеток, выделенных из разных источников</article-title><trans-title-group xml:lang="en"><trans-title>The comparative study of chondrogenic differentiation of mesenchymal stromal cells allocated from different sources</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Басок</surname><given-names>Ю. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Basok</surname><given-names>Yu. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123182, Москва, ул. Щукинская, д. 1.Тел. (499) 193-86-62. </p></bio><bio xml:lang="en"><p>1, Shchukinskaya str., Moscow, 123182. Теl. (499) 193-86-62.</p></bio><email xlink:type="simple">bjb2005@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Григорьев</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Grigoriev</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кирсанова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kirsanova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вахрушев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vakhrushev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цветкова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsvetkova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грядунова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gryadunova</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ярыгин</surname><given-names>К. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Yarygin</surname><given-names>K. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Севастьянов</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sevastianov</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича»; Лаборатория биотехнологических исследований «3Д Биопринтинг Солюшенс»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.N. Orekhovich Institute of Biomedical Chemistry; Private Institution Laboratory for Biotechnological Research «3D Bioprinting Solutions»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.N. Orekhovich Institute of Biomedical Chemistry</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Лаборатория биотехнологических исследований «3Д Биопринтинг Солюшенс»; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Private Institution Laboratory for Biotechnological Research «3D Bioprinting Solutions»; I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovsky University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>17</day><month>05</month><year>2019</year></pub-date><volume>21</volume><issue>1</issue><fpage>101</fpage><lpage>112</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Басок Ю.Б., Григорьев А.М., Кирсанова Л.А., Вахрушев И.В., Цветкова А.В., Грядунова А.А., Ярыгин К.Н., Севастьянов В.И., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Басок Ю.Б., Григорьев А.М., Кирсанова Л.А., Вахрушев И.В., Цветкова А.В., Грядунова А.А., Ярыгин К.Н., Севастьянов В.И.</copyright-holder><copyright-holder xml:lang="en">Basok Y.B., Grigoriev A.M., Kirsanova L.A., Vakhrushev I.V., Tsvetkova A.V., Gryadunova A.A., Yarygin K.N., Sevastianov V.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/996">https://journal.transpl.ru/vtio/article/view/996</self-uri><abstract><sec><title>Введение</title><p>Введение. В качестве альтернативы аутохондротрансплантации рассматриваются варианты замены хондроцитов на мезенхимальные стромальные клетки (МСК), которые присутствуют во всех органах и тканях человеческого организма и обладают мультилинейным потенциалом дифференцировки. В ряде исследований показано, что способность к хондрогенной дифференцировке МСК из разных тканей различается, однако работы, посвященные данному вопросу, единичны и противоречивы. В соответствии с этическими принципами и технической простотой получения наиболее привлекательными для тканевой инженерии источниками МСК представляются жировая ткань, Вартонов студень пуповины (строма) и пульпа зуба.</p><p>Целью настоящего исследования было сравнение хондрогенного потенциала МСК, выделенных из жировой ткани, Вартонова студня пуповины и пульпы молочного зуба человека, при культивировании в составе микросфер (пеллет).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Фенотип первичных культур МСК исследовали методом проточной микроскопии. Хондрогенную дифференцировку проводили при 3D-культивировании в составе микросфер в присутствии TGFβ1 в течение двух недель при стандартных условиях. В качестве положительного контроля использовали хондробласты человека. Жизнеспособность клеток определяли методом флуоресцентного окрашивания. Морфологическое исследование проводили с использованием гистологических и иммуногистохимических методов окрашивания.</p></sec><sec><title>Результаты</title><p>Результаты. Культуры МСК из всех источников обладали сходным фенотипом CD29+, CD34–, CD44+, CD49b+, CD45–, CD73+, CD90+, HLADR. В составе микросфер визуализировались лишь единичные мертвые клетки в массе живых. Значительная продукция внеклеточного матрикса (ВКМ) отмечалась в микросферах из хондробластов и жировой ткани, тогда как в микросферах из МСК пульпы зуба и стромы пуповины выраженной наработки ВКМ не обнаружили. Среди МСК наибольшую наработку коллагена и гликозаминогликанов (ГАГ) в ВКМ наблюдали в микросферах из МСК жировой ткани, а наименьшую – в микросферах из МСК пульпы зуба.</p></sec><sec><title>Заключение</title><p>Заключение. Гистологический анализ всех микросфер через 14 суток культивирования в хондрогенной среде выявил признаки дифференцировки в хондрогенном направлении, прогрессивное увеличение продуцируемого клетками ВКМ и присутствие в нем общего коллагена и ГАГ. Из всех исследованных МСК наибольшим хондрогенным потенциалом in vitro (интенсивность наработки компонентов ВКМ) обладают МСК жировой ткани.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. As an alternative to autochondral transplantation, variants of chondrocyte replacement with mesenchymal stromal cells (MSCs) were considered, since these cells are present in all organs and tissues of human body and possess multilinear potential for differentiation. A number of studies demonstrate that the ability for chondrogenic differentiation of MSCs from different tissues varies, however, those studies are few and controversial. In accordance with the ethical principles and the technical ease of obtaining, adipose tissue, Wharton’s jelly (stroma) and dental pulp are the most attractive sources of MSCs for tissue engineering.</p></sec><sec><title>Aim</title><p>Aim: to compare the chondrogenic potential of MSCs allocated from adipose tissue, Wharton’s jelly of the umbilical cord, and human deciduous teeth pulp cultured in the composition of microspheres (pellets).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The phenotype of primary cultures of MSCs was studied via flow microscopy. Chondrogenic differentiation was performed with 3D-culture in microspheres in the presence of TGFβ1 for two weeks under standard conditions. Human chondroblasts were used as a positive control. Cell viability was determined by fluorescent staining. Morphological study was performed using histological and immunohistochemical staining methods.</p></sec><sec><title>Results</title><p>Results. Cultures of MSCs from all sources had similar phenotypes CD29+, CD34–, CD44+, CD49b+, CD45–, CD73+, CD90+, HLADR. In the mass of living cells in microspheres only singular dead cells were visualized. A significant production of extracellular matrix (ECM) was observed in the chondroblast and adipose tissue microspheres, whereas in the microspheres of dental pulp and umbilical cord stroma derived MSCs, no significant ECM was detected. Among the MSCs, the highest production of collagen and glycosaminoglycans (GAG) in the ECM was observed in the microspheres of adipose tissue-derived MSCs, and the lowest production – in the microspheres of dental pulp-derived MSCs. Conclusion. A histological analysis of all microspheres after 14 days of culturing in the chondrogenic medium revealed the signs of differentiation in the chondrogenic direction, a progressive increase of the ECM produced by cells, and the presence of total collagen and GAG in it. Of all the MSCs studied, the greatest chondrogenic potential in vitro (the intensity of development of ECM components) is possessed by the adipose tissue-derived MSCs.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мезенхимальные стромальные клетки</kwd><kwd>хондрогенная дифференцировка</kwd><kwd>хрящевая ткань</kwd><kwd>тканевая инженерия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mesenchymal stromal cells</kwd><kwd>chondrogenic differentiation</kwd><kwd>cartilage tissue</kwd><kwd>tissue engineering</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">РФФИ, (грант №16-29-07322).</funding-statement><funding-statement xml:lang="en">Russian Foundation for Basic Research, grant No. 16-29-07322.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Caddeo S, Boffito M, Sartori S. Tissue Engineering Approaches in the Design of Healthy and Pathological in vitroTissue Models. Front Bioeng Biotechnol. 2017; 5: 40. doi: 10.3389/fbioe.2017.00040.</mixed-citation><mixed-citation xml:lang="en">Caddeo S, Boffito M, Sartori S. Tissue Engineering Approaches in the Design of Healthy and Pathological in vitroTissue Models. Front Bioeng Biotechnol. 2017; 5: 40. doi: 10.3389/fbioe.2017.00040.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kristjánsson B, Honsawek S. Mesenchymal stem cells for cartilage regeneration in osteoarthritis. World J Orthop. 2017; 8 (9): 674–680. doi: 10.5312/wjo.v8.i9.674.</mixed-citation><mixed-citation xml:lang="en">Kristjánsson B, Honsawek S. Mesenchymal stem cells for cartilage regeneration in osteoarthritis. World J Orthop. 2017; 8 (9): 674–680. doi: 10.5312/wjo.v8.i9.674.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rai V, Dilisio MF, Dietz NE, Agrawal DK. Recent strategies in cartilage repair: A systemic review of the scaffold development and tissue engineering. J Biomed Mater Res A. 2017; 105 (8): 2343–2354. doi: 10.1002/jbm.a.36087.</mixed-citation><mixed-citation xml:lang="en">Rai V, Dilisio MF, Dietz NE, Agrawal DK. Recent strategies in cartilage repair: A systemic review of the scaffold development and tissue engineering. J Biomed Mater Res A. 2017; 105 (8): 2343–2354. doi: 10.1002/jbm.a.36087.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Surguchenko VA, Ponomareva AS, Kirsanova LA, Skaleckij NN, Sevastianov VI. The cell-engineered construct of cartilage on the basis of biopolymer hydrogel matrix and human adipose tissue-derived mesenchymal stromal cells (in vitrostudy). J Biomed Mater Res. Part A. 2015; 103A (2): 463–470. doi: 10.1002/jbm.a.35197.</mixed-citation><mixed-citation xml:lang="en">Surguchenko VA, Ponomareva AS, Kirsanova LA, Skaleckij NN, Sevastianov VI. The cell-engineered construct of cartilage on the basis of biopolymer hydrogel matrix and human adipose tissue-derived mesenchymal stromal cells (in vitrostudy). J Biomed Mater Res. Part A. 2015; 103A (2): 463–470. doi: 10.1002/jbm.a.35197.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shafiee A, Kabiri M, Langroudi L, Soleimani M, Ai J. Evaluation and comparison of the in vitrocharacteristics and chondrogenic capacity of four adult stem/progenitor cells for cartilage cell-based repair. J Biomed Mater Res A. 2016; 104 (3): 600–610. doi: 10.1002/jbm.a.35603.</mixed-citation><mixed-citation xml:lang="en">Shafiee A, Kabiri M, Langroudi L, Soleimani M, Ai J. Evaluation and comparison of the in vitrocharacteristics and chondrogenic capacity of four adult stem/progenitor cells for cartilage cell-based repair. J Biomed Mater Res A. 2016; 104 (3): 600–610. doi: 10.1002/jbm.a.35603.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kohli N, Wright KT, Sammons RL, Jeys L, Snow M, Johnson WE. An in vitroComparison of the Incorporation, Growth, and Chondrogenic Potential of Human Bone Marrow versus Adipose Tissue Mesenchymal Stem Cells in Clinically Relevant Cell Scaffolds Used for Cartilage Repair. Cartilage. 2015; 6 (4): 252–263. doi: 10.1177/1947603515589650.</mixed-citation><mixed-citation xml:lang="en">Kohli N, Wright KT, Sammons RL, Jeys L, Snow M, Johnson WE. An in vitroComparison of the Incorporation, Growth, and Chondrogenic Potential of Human Bone Marrow versus Adipose Tissue Mesenchymal Stem Cells in Clinically Relevant Cell Scaffolds Used for Cartilage Repair. Cartilage. 2015; 6 (4): 252–263. doi: 10.1177/1947603515589650.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ullah M, Hamouda H, Stich S, Sittinger M, Ringe J. A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures. Biores Open Access. 2012; 1 (6): 297–305. doi: 10.1089/biores.2012.0279.</mixed-citation><mixed-citation xml:lang="en">Ullah M, Hamouda H, Stich S, Sittinger M, Ringe J. A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures. Biores Open Access. 2012; 1 (6): 297–305. doi: 10.1089/biores.2012.0279.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Huang L, Yi L, Zhang C, He Y, Zhou L, Liu Y et al. Synergistic Effects of FGF-18 and TGF-β3 on the Chondrogenesis of Human Adipose-Derived Mesenchymal Stem Cells in the Pellet Culture. Stem Cells Int. 2018; 2018: 7139485. doi: 10.1155/2018/7139485.</mixed-citation><mixed-citation xml:lang="en">Huang L, Yi L, Zhang C, He Y, Zhou L, Liu Y et al. Synergistic Effects of FGF-18 and TGF-β3 on the Chondrogenesis of Human Adipose-Derived Mesenchymal Stem Cells in the Pellet Culture. Stem Cells Int. 2018; 2018: 7139485. doi: 10.1155/2018/7139485.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Babur BK, Ghanavi P, Levett P, Lott WB, Klein T, Cooper-White JJ et al. The interplay between chondrocyte redifferentiation pellet size and oxygen concentration. PLoS One. 2013; 8 (3): e58865. doi: 10.1371/journal.pone.0058865.</mixed-citation><mixed-citation xml:lang="en">Babur BK, Ghanavi P, Levett P, Lott WB, Klein T, Cooper-White JJ et al. The interplay between chondrocyte redifferentiation pellet size and oxygen concentration. PLoS One. 2013; 8 (3): e58865. doi: 10.1371/journal.pone.0058865.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Huang S, Song X, Li T, Xiao J, Chen Y, Gong X et al. Pellet coculture of osteoarthritic chondrocytes and infrapatellar fat pad-derived mesenchymal stem cells with chitosan/hyaluronic acid nanoparticles promotes chondrogenic differentiation. Stem Cell Res Ther. 2017; 8 (1): 264. doi: 10.1186/s13287-017-0719-7.</mixed-citation><mixed-citation xml:lang="en">Huang S, Song X, Li T, Xiao J, Chen Y, Gong X et al. Pellet coculture of osteoarthritic chondrocytes and infrapatellar fat pad-derived mesenchymal stem cells with chitosan/hyaluronic acid nanoparticles promotes chondrogenic differentiation. Stem Cell Res Ther. 2017; 8 (1): 264. doi: 10.1186/s13287-017-0719-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fickert S, Gerwien P, Helmert B, Schattenberg T, Weckbach S, Kaszkin-Bettag M, Lehmann L. One-Year Clinical and Radiological Results of a Prospective, Investigator-Initiated Trial Examining a Novel, Purely Autologous 3-Dimensional Autologous Chondrocyte Transplantation Product in the Knee. Cartilage. 2012; 3 (1): 27–42. doi: doi: 10.1177/1947603511417616.</mixed-citation><mixed-citation xml:lang="en">Fickert S, Gerwien P, Helmert B, Schattenberg T, Weckbach S, Kaszkin-Bettag M, Lehmann L. One-Year Clinical and Radiological Results of a Prospective, Investigator-Initiated Trial Examining a Novel, Purely Autologous 3-Dimensional Autologous Chondrocyte Transplantation Product in the Knee. Cartilage. 2012; 3 (1): 27–42. doi: doi: 10.1177/1947603511417616.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8 (4): 315–317. doi: 10.1080/14653240600855905.</mixed-citation><mixed-citation xml:lang="en">Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8 (4): 315–317. doi: 10.1080/14653240600855905.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis MC, MacArthur BD, Tare RS, Oreffo RO, Please CP. Extracellular Matrix Deposition in Engineered Micromass Cartilage Pellet Cultures: Measurements and Modelling. PLoS One. 2016; 11 (2): e0147302. doi: 10.1371/journal.pone.0147302.</mixed-citation><mixed-citation xml:lang="en">Lewis MC, MacArthur BD, Tare RS, Oreffo RO, Please CP. Extracellular Matrix Deposition in Engineered Micromass Cartilage Pellet Cultures: Measurements and Modelling. PLoS One. 2016; 11 (2): e0147302. doi: 10.1371/journal.pone.0147302.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sevastianov VI, Basok YB, Grigor’ev AM, Kirsanova LA, Vasilets VN. Formation of Tissue-Engineered Construct of Human Cartilage Tissue in a Flow-Through Bioreactor. Bull Exp Biol Med. 2017; 164 (2): 269–273. doi: 10.1007/s10517-017-3971-z.</mixed-citation><mixed-citation xml:lang="en">Sevastianov VI, Basok YB, Grigor’ev AM, Kirsanova LA, Vasilets VN. Formation of Tissue-Engineered Construct of Human Cartilage Tissue in a Flow-Through Bioreactor. Bull Exp Biol Med. 2017; 164 (2): 269–273. doi: 10.1007/s10517-017-3971-z.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Körsmeier K, Claßen T, Kamminga M, Rekowski J, Jäger M, Landgraeber S. Arthroscopic three-dimensional autologous chondrocyte transplantation using spheroids for the treatment of full-thickness cartilage defects of the hip joint. Knee Surg Sports Traumatol Arthrosc. 2016; 24 (6): 2032–2037. doi: 10.1007/s00167-014-3293-x.</mixed-citation><mixed-citation xml:lang="en">Körsmeier K, Claßen T, Kamminga M, Rekowski J, Jäger M, Landgraeber S. Arthroscopic three-dimensional autologous chondrocyte transplantation using spheroids for the treatment of full-thickness cartilage defects of the hip joint. Knee Surg Sports Traumatol Arthrosc. 2016; 24 (6): 2032–2037. doi: 10.1007/s00167-014-3293-x.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu M, Matsumoto T, Kikuta S, Ohtaki M, Kano K, Taniguchi H et al. Transplantation of dedifferentiated fat cell-derived micromass pellets contributed to cartilage repair in the rat osteochondral defect model. J Orthop Sci. 2018; 23 (4): 688–696. doi: 10.1016/j.jos.2018.03.001.</mixed-citation><mixed-citation xml:lang="en">Shimizu M, Matsumoto T, Kikuta S, Ohtaki M, Kano K, Taniguchi H et al. Transplantation of dedifferentiated fat cell-derived micromass pellets contributed to cartilage repair in the rat osteochondral defect model. J Orthop Sci. 2018; 23 (4): 688–696. doi: 10.1016/j.jos.2018.03.001.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zajdel A, Kałucka M, Kokoszka-Mikołaj E, Wilczok A. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton’s jelly of the umbilical cord. Acta Biochim Pol. 2017; 64 (2): 365–369. doi: 10.18388/abp.2016_1488.</mixed-citation><mixed-citation xml:lang="en">Zajdel A, Kałucka M, Kokoszka-Mikołaj E, Wilczok A. Osteogenic differentiation of human mesenchymal stem cells from adipose tissue and Wharton’s jelly of the umbilical cord. Acta Biochim Pol. 2017; 64 (2): 365–369. doi: 10.18388/abp.2016_1488.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">White JL, Walker NJ, Hu JC, Borjesson D, Athanasiou KA. A comparison of bone marrow and cord blood mesenchymal stem cells for cartilage self-assembly. Tissue Eng Part A. 2018; 24 (15–16): 1262–1272. doi: 10.1089/ten.TEA.2017.0424.</mixed-citation><mixed-citation xml:lang="en">White JL, Walker NJ, Hu JC, Borjesson D, Athanasiou KA. A comparison of bone marrow and cord blood mesenchymal stem cells for cartilage self-assembly. Tissue Eng Part A. 2018; 24 (15–16): 1262–1272. doi: 10.1089/ten.TEA.2017.0424.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Westin CB, Trinca RB, Zuliani C, Coimbra IB, Moraes ÂM. Differentiation of dental pulp stem cells into chondrocytes upon culture on porous chitosan-xanthan scaffolds in the presence of kartogenin. Mater Sci Eng C Mater Biol Appl. 2017; 80: 594–602. doi: 10.1016/j.msec.2017.07.005.</mixed-citation><mixed-citation xml:lang="en">Westin CB, Trinca RB, Zuliani C, Coimbra IB, Moraes ÂM. Differentiation of dental pulp stem cells into chondrocytes upon culture on porous chitosan-xanthan scaffolds in the presence of kartogenin. Mater Sci Eng C Mater Biol Appl. 2017; 80: 594–602. doi: 10.1016/j.msec.2017.07.005.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandes TL, Shimomura K, Asperti A, Pinheiro CCG, Caetano HVA, Oliveira CRGCM et al. Development of a Novel Large Animal Model to Evaluate Human Dental Pulp Stem Cells for Articular Cartilage Treatment. Stem Cell Rev. 2018; 14 (5): 734–743. doi: 10.1007/s12015-018-9820-2.</mixed-citation><mixed-citation xml:lang="en">Fernandes TL, Shimomura K, Asperti A, Pinheiro CCG, Caetano HVA, Oliveira CRGCM et al. Development of a Novel Large Animal Model to Evaluate Human Dental Pulp Stem Cells for Articular Cartilage Treatment. Stem Cell Rev. 2018; 14 (5): 734–743. doi: 10.1007/s12015-018-9820-2.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Вавилова ТП. Биохимия тканей и жидкостей полостей рта: учебное пособие. М.: ГЭОТАР Медиа, 2008: 208.</mixed-citation><mixed-citation xml:lang="en">Vavilova TP. Biohimija tkanej i zhidkostej polostej rta: uchebnoe posobie. M.: GJeOTAR Media, 2008: 208.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
